Search research articles
Contact Us
Filters
Showing results (41-50 of 564) with videos related to
Page
of 57
Sort By:
Oral Surgery, Oral Medicine, and Oral Pathology
|
August 1, 1977
Retrieval of broken instrument from root canal
R N Sternberg
European Urology
|
June 16, 2016
Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial
Cora N Sternberg
European Urology
|
June 4, 2016
Improving Survival for Metastatic Castrate-resistant Prostate Cancer: Will Combination Therapy Help Us To Move Forward?
Cora N Sternberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel hormonal therapy for castration-resistant prostate cancer
C N Sternberg
Future Oncology (London, England)
|
March 9, 2019
Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
Cora N Sternberg
Nature Clinical Practice. Urology
|
August 12, 2006
Adjuvant bicalutamide for early prostate cancer: an update
Cora N Sternberg
Progress in Clinical and Biological Research
|
January 1, 1992
Post cystectomy adjuvant chemotherapy: a clinical routine?
C N Sternberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2006
Are nomograms better than currently available stage groupings for bladder cancer?
Cora N Sternberg
Nature Clinical Practice. Urology
|
July 9, 2008
Antiangiogenic therapy in renal cell carcinoma: a plethora of choices
Cora N Sternberg
Nature Clinical Practice. Urology
|
July 12, 2007
Molecular pathways and the hope of targeting angiogenesis
Cora N Sternberg
Page
of 57
Search research articles
Search
Showing results (41-50 of 564) with videos related to
Sort By:
Page
of 57
Oral Surgery, Oral Medicine, and Oral Pathology
|
August 1, 1977
Retrieval of broken instrument from root canal
R N Sternberg
European Urology
|
June 16, 2016
Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial
Cora N Sternberg
European Urology
|
June 4, 2016
Improving Survival for Metastatic Castrate-resistant Prostate Cancer: Will Combination Therapy Help Us To Move Forward?
Cora N Sternberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2012
Novel hormonal therapy for castration-resistant prostate cancer
C N Sternberg
Future Oncology (London, England)
|
March 9, 2019
Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
Cora N Sternberg
Nature Clinical Practice. Urology
|
August 12, 2006
Adjuvant bicalutamide for early prostate cancer: an update
Cora N Sternberg
Progress in Clinical and Biological Research
|
January 1, 1992
Post cystectomy adjuvant chemotherapy: a clinical routine?
C N Sternberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2006
Are nomograms better than currently available stage groupings for bladder cancer?
Cora N Sternberg
Nature Clinical Practice. Urology
|
July 9, 2008
Antiangiogenic therapy in renal cell carcinoma: a plethora of choices
Cora N Sternberg
Nature Clinical Practice. Urology
|
July 12, 2007
Molecular pathways and the hope of targeting angiogenesis
Cora N Sternberg
Page
of 57